Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

BUY
$48.82 - $65.05 $15,817 - $21,076
324 Added 22.55%
1,761 $101,000
Q1 2025

May 12, 2025

SELL
$56.03 - $88.57 $71,606 - $113,192
-1,278 Reduced 47.07%
1,437 $83,000
Q4 2024

Feb 14, 2025

SELL
$67.27 - $99.45 $32,087 - $47,437
-477 Reduced 14.94%
2,715 $218,000
Q3 2024

Nov 07, 2024

BUY
$56.31 - $84.99 $55,240 - $83,375
981 Added 44.37%
3,192 $255,000
Q2 2024

Jul 26, 2024

BUY
$45.73 - $69.19 $101,109 - $152,979
2,211 New
2,211 $135,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $1.32B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track River Park Advisors, LLC Portfolio

Follow River Park Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Park Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Park Advisors, LLC with notifications on news.